Keyphrases
Cerebrospinal Fluid Biomarkers
100%
Clinical Dementia Rating
100%
Alzheimer's Disease Diagnosis
100%
Disease Prognosis
100%
Multiplex Immunoassay
100%
Cognitive Impairment
18%
Alzheimer's Disease Pathology
18%
Cognitively Normal
18%
Novel Biomarkers
18%
Targeted Proteomics
18%
Calbindin
18%
Patient Care
9%
Cox Proportional Hazards Model
9%
Receiver Operating Characteristic Analysis
9%
Risk Prediction
9%
Diagnostic Accuracy
9%
Early Alzheimer's Disease
9%
Dementia Onset
9%
N-terminal Pro-brain Natriuretic Peptide (NT-proBNP)
9%
Proteomic Approach
9%
Prognostic Potential
9%
Diagnostic Performance
9%
Multiplexing
9%
Machine Learning Algorithms
9%
P-tau181
9%
Fibrinogen
9%
Cerebrospinal Fluid Samples
9%
Clinical Trial Design
9%
Luminex
9%
Prognostic Accuracy
9%
Biomarker Panel
9%
ROC Analysis
9%
MMP-10
9%
Plasminogen Activator inhibitor-1 (PAI-1)
9%
Bonferroni Correction
9%
Eotaxin
9%
Multiple Machines
9%
Machine Learning Models
9%
Cystatin C (Cys C)
9%
Medical Attention
9%
Proteomic Screen
9%
0-group
9%
TRAIL-R3
9%
Biochemistry, Genetics and Molecular Biology
Liquid
100%
Immunoassay
100%
Tau
33%
Calbindin
33%
Proteomics
33%
Vitamin D-Dependent Calcium-Binding Protein
33%
Vascular Endothelial Growth Factor
16%
TRAIL
16%
Clinical Trial Design
16%
Stromelysin 2
16%
Plasminogen Activator Inhibitor-1
16%
Eotaxin
16%
Cystatin C
16%
Fibrinogen
16%